VREfm 1 |
Chronic mylogenous leukaemia |
>256 |
vanA |
PEN-CIP-VAN-TEC-AMP-LNZ |
tetM |
esp-acm |
ST78(CC17) |
VREfm 2 |
Acute lymphocytic leukaemia |
>128 |
vanA |
PEN-CIP-VAN-TEC-AMP |
tetM |
esp-acm |
ST78(CC17) |
VREfm 3 |
Chronic mylogenous leukaemia |
>256 |
vanA |
PEN-CIP-VAN-TEC-AMP-GEH-TCY |
tetM-aph |
esp-acm |
ST78(CC17) |
VREfm 4 |
Acute lymphocytic leukaemia |
>256 |
vanA |
PEN-CIP-VAN-TEC-AMP-GEH-TCY |
tetM-aph |
esp-acm |
ST17(CC17) |
VREfm 5 |
Acute lymphocytic leukaemia |
>128 |
vanA |
PEN-CIP-VAN-AMP--TCY |
tetM-aph |
esp-acm |
ST78(CC17) |
VREfm 6 |
Mixed phenotype acute leukemia, Lung and skin infections, Broad-spectrum anti-infectious treatment |
>256 |
vanA |
PEN-CIP-VAN-TEC-AMP-GEH |
tetM-aph |
acm |
ST203(CC17) |
VREfm 7 |
Acute lymphocytic leukaemia |
>256 |
vanA |
PEN-CIP-VAN-AMP-GEH-TCY |
aph |
esp-acm |
ST203(CC17) |
VREfm 8 |
Chronic mylogenous leukaemia |
>256 |
vanA |
PEN-CIP-VAN-TEC-AMP-GEH-TCY |
tetM-aph |
esp-acm |
ST78(CC17) |